Press Release July 7, 2021Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine 0 0 Share
Company Ticker News July 7, 2021Moderna begins Phase 1/2 trial for experimental flu vaccine 0 0 Share
Company Ticker News July 7, 2021Moderna Begins Human Study Of MRNA-Based Flu Shot After Covid Success 0 0 Share
Company Ticker News July 7, 2021Has Moderna (MRNA) Outpaced Other Medical Stocks This Year? 0 0 Share
Company Ticker News July 7, 2021South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: Reuters 0 0 Share